Skip to main content

Market Overview

Why Rallybio Shares Are Trading Higher By Around 78%; Here Are 20 Stocks Moving Premarket

Share:
Why Rallybio Shares Are Trading Higher By Around 78%; Here Are 20 Stocks Moving Premarket

Shares of Rallybio Corporation (NASDAQ: RLYB) rose sharply in today’s pre-market trading after the company announced a collaboration with Johnson & Johnson to advance therapeutics for pregnant individuals at risk of FNAIT.

Rallybio shares jumped rose 77.9% to $2.90 in pre-market trading.

Here are some other stocks moving in pre-market trading.

Gainers

  • Rent the Runway, Inc. (NASDAQ: RENT) shares rose 40.8% to $10.42 in pre-market trading after the company reported mixed fourth-quarter financial results and issued guidance.
  • Alpine Immune Sciences, Inc. (NASDAQ: ALPN) gained 36.1% to $64.02 in pre-market trading after Vertex entered into an agreement to acquire the company.
  • TuanChe Limited (NASDAQ: TC) shares gained 24.4% to $2.24 in pre-market trading after falling 8% on Wednesday.
  • Verb Technology Company, Inc. (NASDAQ: VERB) gained 18.5% to $0.2156 in pre-market trading after gaining 4% on Wednesday.
  • Vera Therapeutics, Inc. (NASDAQ: VERA) climbed 13.1% to $47.06 in pre-market trading after gaining 10% on Wednesday.
  • BitFuFu Inc. (NASDAQ: FUFU) shares gained 12.5% to $4.90 in pre-market trading after reporting full year 2023 financial results.
  • Allarity Therapeutics, Inc. (NASDAQ: ALLR) rose 10.2% to $3.56 in pre-market trading after dipping 10% on Wednesday.
  • CuriosityStream Inc. (NASDAQ: CURI) gained 10.8% to $1.58 in pre-market trading after surging over 10% on Wednesday. Curiosity Stream, on March 20, reported mixed fourth-quarter financial results.
  • SciSparc Ltd. (NASDAQ: SPRC) shares rose 8.3% to $1.82 in pre-market trading.

Losers

  • Aptevo Therapeutics Inc. (NASDAQ: APVO) fell 31.3% to $1.65 in pre-market trading. Aptevo Therapeutics recently issued pipeline update.
  • Acorda Therapeutics, Inc. (NASDAQ: ACOR) fell 17.7% to $0.7158 in pre-market trading after declining 14% on Wednesday. Acorda Therapeutics recently commenced voluntary proceedings under Chapter 11 of the United States Bankruptcy Code.
  • ClearOne, Inc. (NASDAQ: CLRO) declined 17.1% to $0.9046 in pre-market trading. The company recently reported fourth-quarter financial results.
  • SolarBank Corporation (NASDAQ: SUUN) fell 14.4% to $4.98 in pre-market trading. SolarBank closed purchase of 3.15 MW solar project in New York from Storke Renewable.
  • Meiwu Technology Company Limited (NASDAQ: WNW) shares declined 13.4% to $1.15 in pre-market trading after jumping around 32% on Wednesday.
  • Novo Integrated Sciences, Inc. (NASDAQ: NVOS) fell 12.7% to $0.4452 pre-market trading after declining around 4% on Wednesday.
  • iCoreConnect Inc. (NASDAQ: ICCT) shares fell 9.5% to $1.53 in pre-market trading after jumping over 50% on Wednesday.
  • Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) shares fell 9.3% to $2.11 in pre-market trading. Adial Pharmaceuticals shares jumped 106% on Wednesday after the company announced the publication of a peer-reviewed article highlighting the clinical results, strong safety profile, and high compliance among patients administered AD04.
  • Nyxoah S.A. (NASDAQ: NYXH) fell 8.3% to $9.74 in pre-market trading.
  • AVITA Medical, Inc. (NASDAQ: RCEL) fell 4.2% to $13.83 pre-market trading after the company announced an update to its expected commercial revenue for the first quarter of 2024.

 

Now Read This: Jim Cramer Says WESCO International Is A Buy, Recommends Buying This Stock Under $20

 

 

Related Articles (RLYB)

View Comments and Join the Discussion!

Posted-In: Premarket MoversNews Penny Stocks Small Cap Pre-Market Outlook Markets Movers Trading Ideas Best of Benzinga

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com